UBS Group »

Arrowhead Pharmaceuticals shares owned by UBS Group

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $16M 509k 30.60
2023-09-30 $9.9M 370k 26.87
2023-06-30 $12M 331k 35.69
2023-03-31 $7.6M 299k 25.40
2022-12-31 $13M 308k 40.56
2022-09-30 $3.4M 104k 33.02
2022-06-30 $3.2M 91k 35.21
2022-03-31 $7.4M 159k 46.49
2021-12-31 $10M 155k 66.30
2021-09-30 $8.1M 130k 62.43
2021-06-30 $6.0M 72k 82.85
2021-03-31 $4.8M 72k 66.32
2020-12-31 $887k 12k 76.76
2020-09-30 $1.4M 33k 43.06
2020-06-30 $337k 7.8k 43.18
2020-03-31 $347k 12k 28.81
2019-12-31 $13M 208k 63.42
2019-09-30 $6.0M 211k 28.18
2019-06-30 $3.0M 114k 26.49
2019-03-31 $1.0M 55k 18.33
2018-12-31 $3.5M 279k 12.42
2018-09-30 $1.6M 84k 19.16
2018-06-30 $451k 33k 13.61
2018-03-31 $1.5M 203k 7.21
2017-12-31 $70k 23k 3.12
2017-09-30 $51k 12k 4.30
2017-06-30 $9.5k 5.7k 1.68
2017-03-31 $10k 5.3k 1.89
2016-12-31 $23k 15k 1.57
2016-09-30 $154k 21k 7.35
2016-06-30 $43k 8.6k 5.00